Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-14

Clinical Trial Update: New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed new adjuvant chemotherapy for patients with asymptomatic resectable primary colorectal tumors and unresectable liver-limited metastases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: Colorectal Neoplasms, Neoplasm Metastasis | Phase 3 | Status: COMPLETED